Title: Addex Therapeutics Reports Half-Year 2025 Financial Results and Provides Corporate Update Date: October 1, 2025 Time: 16:00 CEST (15:00 BST / 10:00 EDT / 07:00 PDT) ...
OSE Immunotherapeutics, Inserm Transfert and Nantes University Announce Strategic Partnership to Accelerate Innovation in Immunotherapy ...
Leerink Partners, Stifel, Guggenheim Securities and Van Lanschot Kempen are acting as bookrunning managers for the offering. H.C. Wainwright & Co. is acting as lead manager for the offering.
OSE Immunotherapeutics, Inserm Transfert et Nantes Université annoncent un partenariat stratégique pour accélérer l’innovation en immunothérapie ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback